efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma
Published 2 months ago • 112 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
2:47
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma - blood cancers onctalk 2023
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
2:52
bispecific antibody treatment in non-hodgkin lymphoma: glofitamab - blood cancers onctalk 2023
-
1:19
q&a: do bispecifics cure diffuse large b-cell lymphoma? - blood cancer onctalk 2023
-
4:53
immunotherapy treatments b-cell non-hodgkin's: bispecific antibodies - blood cancer video library
-
3:52
glofitamab & pirtobrutinib for relapsed/refractory mantle cell lymphoma -blood cancers video library
-
5:13
emerging immunotherapy treatments for b-cell non-hodgkin's lymphoma: bispecific antibodies
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
1:31
advantages of bispecific antibodies for lymphoma: mosunetuzumab, epcoritamab & glofitamab
-
3:56
bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
3:12
what are the pros and cons of car t-cell therapy vs. bispecific antibodies? - blood cancer onctalk
-
3:34
transplants in myeloma and lymphoma: effects on survival - blood cancer onctalk 2023
-
19:05
what we know about immunotherapy treatments for lung cancer
-
4:44
mosunetuzumab for follicular lymphoma - blood cancer onctalk 2023